Search Results

There are 1320017 results for: content related to: In this issue

  1. Efficacy of just-in-time plerixafor rescue for Hodgkin's lymphoma patients with poor peripheral blood stem cell mobilization

    Transfusion

    Volume 54, Issue 8, August 2014, Pages: 2015–2021, Shan Yuan, Auayporn Nademanee, Mark Kaniewski, Joycelynne Palmer, Sepideh Shayani and Shirong Wang

    Version of Record online : 24 MAR 2014, DOI: 10.1111/trf.12594

  2. Impact of plerixafor (mozobil) on hospital efficiency: a single center experience

    Journal of Clinical Apheresis

    Nabih Azar, Maya Ouzegdouh, Sylvain Choquet and Véronique Leblond

    Version of Record online : 28 APR 2017, DOI: 10.1002/jca.21551

  3. You have free access to this content
    A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteers

    British Journal of Haematology

    Volume 153, Issue 1, April 2011, Pages: 66–75, Steven J. Lemery, Matthew M. Hsieh, Aleah Smith, Sheila Rao, Hanh M. Khuu, Donohue Theresa, Jennifer M. Viano, Lisa Cook, Rose Goodwin, Carol Boss, Gary Calandra, Nancy Geller, John Tisdale and Richard Childs

    Version of Record online : 24 FEB 2011, DOI: 10.1111/j.1365-2141.2010.08547.x

  4. You have free access to this content
    How do we mobilize and collect autologous peripheral blood stem cells?

    Transfusion

    Volume 57, Issue 1, January 2017, Pages: 13–23, Shan Yuan and Shirong Wang

    Version of Record online : 12 OCT 2016, DOI: 10.1111/trf.13868

  5. Plerixafor as First- and Second-Line Strategies for Autologous Stem Cell Mobilization in Patients with Non-Hodgkin's Lymphoma or Multiple Myeloma

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 7, July 2012, Pages: 596–603, Kevin W. Lor, Pieter J. Helmons, Helen Belew, James R. Lane and Edward D. Ball

    Version of Record online : 3 JUL 2012, DOI: 10.1002/j.1875-9114.2012.01096.x

  6. You have free access to this content
    Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma

    Intervention Review

    The Cochrane Library

    Tim Hartmann, Kai Hübel, Ina Monsef, Andreas Engert and Nicole Skoetz

    Published Online : 20 OCT 2015, DOI: 10.1002/14651858.CD010615.pub2

  7. Engraftment and outcome after autologous stem cell transplantation in plerixafor-mobilized non-Hodgkin's lymphoma patients

    Transfusion

    Volume 54, Issue 5, May 2014, Pages: 1243–1250, Ville Varmavuo, Johanna Rimpiläinen, Hanne Kuitunen, Anne Nihtinen, Kaija Vasala, Maija Mikkola, Anu Kutila, Päivi Lehtonen, Taru Kuittinen, Pentti Mäntymaa, Tapio Nousiainen, Outi Kuittinen and Esa Jantunen

    Version of Record online : 30 SEP 2013, DOI: 10.1111/trf.12434

  8. You have free access to this content
    Patients' outcome after rescue plerixafor administration for autologous stem cell mobilization: a single-center retrospective analysis

    Transfusion

    Volume 57, Issue 1, January 2017, Pages: 115–121, Silvia Spoerl, Robert Peter, Dagmar Wäscher, Katharina Götze, Mareike Verbeek, Christian Peschel and Angela M. Krackhardt

    Version of Record online : 18 NOV 2016, DOI: 10.1111/trf.13883

  9. Second time a charm? Remobilization of peripheral blood stem cells with plerixafor in patients who previously mobilized poorly despite using plerixafor as a salvage agent

    Transfusion

    Volume 53, Issue 12, December 2013, Pages: 3244–3250, Shan Yuan, Auayporn Nademanee, Amrita Krishnan, Neil Kogut, Sepideh Shayani and Shirong Wang

    Version of Record online : 22 APR 2013, DOI: 10.1111/trf.12198

  10. Effectiveness and cost analysis of “just-in-time” salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics

    Transfusion

    Volume 51, Issue 10, October 2011, Pages: 2175–2182, Jie Li, Ellie Hamilton, Louette Vaughn, Michael Graiser, Heather Renfroe, Mary Jo Lechowicz, Amelia Langston, Jefferson Mark Prichard, Darlene Anderson, Charise Gleason, Sagar Lonial, Christopher R. Flowers, Jonathan L. Kaufman and Edmund K. Waller

    Version of Record online : 14 APR 2011, DOI: 10.1111/j.1537-2995.2011.03136.x

  11. The evolving role of plerixafor in hematopoietic progenitor cell mobilization

    Transfusion

    Volume 53, Issue 10, October 2013, Pages: 2314–2326, Yvette C. Tanhehco, Dan T. Vogl, Edward A. Stadtmauer and Una O'Doherty

    Version of Record online : 30 JAN 2013, DOI: 10.1111/trf.12102

  12. Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: a prospective comparison

    Transfusion

    Volume 55, Issue 10, October 2015, Pages: 2358–2368, Jaakko Valtola, Ville Varmavuo, Antti Ropponen, Anne Nihtinen, Anu Partanen, Kaija Vasala, Päivi Lehtonen, Karri Penttilä, Marja Pyörälä, Taru Kuittinen, Raija Silvennoinen, Tapio Nousiainen, Jukka Pelkonen, Pentti Mäntymaa and Esa Jantunen

    Version of Record online : 28 MAY 2015, DOI: 10.1111/trf.13170

  13. A nationwide survey of the use of plerixafor in patients with lymphoid malignancies who mobilize poorly demonstrates the predominant use of the “on-demand” scheme of administration at French autologous hematopoietic stem cell transplant programs

    Transfusion

    Volume 55, Issue 9, September 2015, Pages: 2149–2157, Christian Chabannon, Fontanet Bijou, Jean-Michel Miclea, Noel Milpied, Jean-Marie Grouin and Mohamad Mohty

    Version of Record online : 13 MAY 2015, DOI: 10.1111/trf.13141

  14. You have full text access to this OnlineOpen article
    Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myeloma

    Transfusion

    Volume 55, Issue 2, February 2015, Pages: 275–283, Jian Cheng, Michael Schmitt, Patrick Wuchter, Eike C. Buss, Mathias Witzens-Harig, Kai Neben, Michael Hundemer, Jens Hillengass, Renate Alexi, Hartmut Goldschmidt, Bao-an Chen, Anthony D. Ho and Anita Schmitt

    Version of Record online : 13 AUG 2014, DOI: 10.1111/trf.12813

  15. Preemptive use of plerixafor in difficult-to-mobilize patients: an emerging concept

    Transfusion

    Volume 52, Issue 4, April 2012, Pages: 906–914, Esa Jantunen and Roberto M. Lemoli

    Version of Record online : 7 OCT 2011, DOI: 10.1111/j.1537-2995.2011.03349.x

  16. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models

    The Prostate

    Volume 75, Issue 12, September 1, 2015, Pages: 1227–1246, Giovanni Luca Gravina, Andrea Mancini, Paola Muzi, Luca Ventura, Leda Biordi, Enrico Ricevuto, Simona Pompili, Claudia Mattei, Ernesto Di Cesare, Emmanuele A. Jannini and Claudio Festuccia

    Version of Record online : 12 JUN 2015, DOI: 10.1002/pros.23007

  17. You have full text access to this OnlineOpen article
    The CXCR4 and adhesion molecule expression of CD34+ hematopoietic cells mobilized by “on-demand” addition of plerixafor to granulocyte–colony-stimulating factor

    Transfusion

    Volume 54, Issue 9, September 2014, Pages: 2325–2335, Tamara Girbl, Verena Lunzer, Richard Greil, Konrad Namberger and Tanja Nicole Hartmann

    Version of Record online : 28 MAR 2014, DOI: 10.1111/trf.12632

  18. Peripheral blood stem cell mobilization in multiple myeloma patients treat in the novel therapy-era with plerixafor and G-CSF has superior efficacy but significantly higher costs compared to mobilization with low-dose cyclophosphamide and G-CSF

    Journal of Clinical Apheresis

    Volume 28, Issue 5, October 2013, Pages: 359–367, Lubna Chaudhary, Farrukh Awan, Aaron Cumpston, Sonia Leadmon, Kathy Watkins, William Tse, Michael Craig and Mehdi Hamadani

    Version of Record online : 14 JUN 2013, DOI: 10.1002/jca.21280

  19. Blood graft composition after plerixafor injection in patients with NHL

    European Journal of Haematology

    Volume 89, Issue 2, August 2012, Pages: 128–135, Ville Varmavuo, Pentti Mäntymaa, Tapio Nousiainen, Piia Valonen, Taru Kuittinen and Esa Jantunen

    Version of Record online : 24 MAY 2012, DOI: 10.1111/j.1600-0609.2012.01794.x

  20. Efficacy of pre-emptively used plerixafor in patients mobilizing poorly after chemomobilization: a single centre experience

    European Journal of Haematology

    Volume 86, Issue 4, April 2011, Pages: 299–304, Esa Jantunen, Taru Kuittinen, Eija Mahlamäki, Marja Pyörälä, Pentti Mäntymaa and Tapio Nousiainen

    Version of Record online : 31 JAN 2011, DOI: 10.1111/j.1600-0609.2010.01573.x